{
    "title": "AstraZeneca's Lynparza meets secondary goal in prostate cancer study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8252523/AstraZenecas-Lynparza-meets-secondary-goal-prostate-cancer-study.html",
    "date": "2020-04-24",
    "keywords": [
        "cancer",
        "study",
        "goal",
        "prostate",
        "drug",
        "latestage",
        "effectiveness",
        "company",
        "lynparza",
        "castrationresistant",
        "brca12",
        "gene",
        "anticancer",
        "enzalutamide",
        "httpswwwastrazenecacommediacentrepressreleases2020lynparzashowsoverallsurvivalinprostatecancerhtml",
        "httpswwwreuterscomarticleusastrazenecalynparzatrialastrazenecaslynparzahelpsprostatecancerpatientslivelongerstudyiduskcn1ux0l1",
        "august",
        "year",
        "reporting",
        "pushkala",
        "aripaka",
        "bengaluru",
        "editing",
        "patrick",
        "graham"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}